P53 mutation and c-fos overexpression are associated with detection of the antigen VLA-2 in human melanoma cell lines.
In this study, we examined the expression of c-fos, c-myc, mutant c-Ha-ras and mutant p53 proteins in three normal human melanocyte cell lines and the following 12 melanoma cell lines: M5, Mewo, A375, Bro, Mel 2a, O-Mel II, IgR 39, SkMel-13, -19, -28 Mel-57 and NKI-4, using an immunohistochemical assay (APAAP). An effort was made to correlate oncogene expression with growth parameters, differentiation antigens (HMB-45, vla-2, k.1.2.58, HLA-DR, HLA-I), and pigmentation. All melanocyte cell lines were negative for the oncogenes examined, whereas six of the melanoma cell lines were found also positive (three for c-fos, two for c-myc, one for c-Ha-ras, and four for p53). Three melanoma cell lines expressed one oncogene and three the combination c-fos/p53. These three melanoma cell lines were positive for the "late" tumor progression marker A. 1.43 (vla-2 adhesion molecule) and negative for the differentiation marker k. 1. 2. 58. Positivity for A. 1. 43 combined with negative staining for k. 1. 2. 58 was found in six out of the 12 cell lines. The observed oncogene expression correlated neither with growth parameters nor melanin content. The present findings revealed a coexpression of mutant p53 and c-fos proteins being associated with a highly malignant phenotype in melanoma cell lines. Further studies are necessary to clarify the significance of the above findings.
Kroumpouzos
G
G
Department of Dermatology, University Medical Center Steglitz, Free University of Berlin, Germany.
Eberle
J
J
Garbe
C
C
Orfanos
C E
CE
D014408:Biomarkers, Tumor / Q000032:analysis; D015870:Gene Expression; D016762:Genes, fos; D016158:Genes, p53; D006801:Humans; D007150:Immunohistochemistry; D008545:Melanoma / Q000235:genetics* / Q000276:immunology; D009154:Mutation; D016760:Proto-Oncogene Proteins c-fos / Q000032:analysis; D016029:Receptors, Very Late Antigen / Q000032:analysis*; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000032:analysis
D014408:Biomarkers, Tumor; D016760:Proto-Oncogene Proteins c-fos; D016029:Receptors, Very Late Antigen; D016159:Tumor Suppressor Protein p53